Novo Nordisk just got a reality check. The company's latest trial for a higher-dose Wegovy showed it helps patients shed more ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of medicines containing semaglutide following ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Pepper Lunch is a Japanese restaurant that has used customer feedback on food portions to adjust its menu. Angel Chen, a master’s student in nutritional sciences at California State University ...

The United States is set to fall in worldwide life expectancy ranking by mid-century, with widespread obesity adversely impacting people’s health, according to a recent study. The peer-reviewed ...

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it could happen much sooner than later. The analysts pointed to ...

One example is the weight-loss medication Wegovy, which was approved for cardiovascular ... "This is the first needle-free option for those with severe allergies and a fear of needles," he said.